Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. Mark ColemanIndependent Lead Director | -17,54k | 4,02M | Automatic Disposition | 223,39 - 233,46 | 433,46k | -3,89% |
| 2026-05-04 | Mr. Mark L. JacobsonCOO | -4,75k | 1,02M | Derivative Exercise and Sale | 12,95 - 228,18 | 0,00 | - |
| 2026-04-22 | Mr. Ari MaizelChief Commercial Officer | -7,50k | 837,68k | Derivative Exercise and Sale | 70,73 - 182,42 | 0,00 | - |
| 2026-02-26 | Dr. Mark ColemanIndependent Lead Director | -25,00k | 4,03M | Automatic Disposition | 161,11 | 451,00k | -5,25% |
| 2026-02-26 | Mr. Mark L. JacobsonCOO | -35,38k | 5,63M | Derivative Exercise and Sale | 2,85 - 161,88 | 0,00 | - |
| 2026-02-23 | Dr. Mark ColemanIndependent Lead Director | 6,25k | 30,94k | Derivative Exercise and Retained Stock | 4,95 | 476,00k | 1,33% |
| 2026-02-20 | Dr. Mark ColemanIndependent Lead Director | 12,49k | 61,80k | Derivative Exercise and Retained Stock | 4,95 | 469,75k | 2,73% |
| 2026-02-10 | Dr. Mark ColemanIndependent Lead Director | 5,19k | 41,65k | Derivative Exercise and Retained Stock | 8,02 | 457,26k | 1,15% |
| 2026-02-02 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -32,41k | 5,76M | Derivative Exercise and Sale | 8,02 - 185,60 | 7,23k | - |
| 2026-01-21 | Mr. Ari MaizelChief Commercial Officer | -7,50k | 852,83k | Derivative Exercise and Sale | 70,73 - 184,44 | 0,00 | - |
| 2026-01-22 | Mr. Nick PizzieCFO | -12,00k | 2,21M | Derivative Exercise and Sale | 3,50 - 187,92 | 43,08k | - |
| 2026-01-05 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -139,41k | 22,76M | Derivative Exercise and Sale | 8,02 - 172,33 | 7,23k | - |
| 2025-12-31 | Mr. Mark E. SaadIndependent Director | -37,58k | 6,00M | Derivative Exercise and Sale | 4,95 - 165,18 | 10,30k | - |
| 2025-12-02 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -79,97k | 11,01M | Derivative Exercise and Sale | 8,02 - 148,18 | 7,23k | - |
| 2025-11-03 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -163,94k | 20,50M | Derivative Exercise and Sale | 8,02 - 134,49 | 7,23k | - |
| 2025-10-06 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -45,38k | 5,05M | Derivative Exercise and Sale | 8,02 - 120,17 | 7,23k | - |
| 2025-09-22 | Mr. Mark L. JacobsonCOO | -10,00k | 1,13M | Derivative Exercise and Sale | 2,85 - 115,96 | 0,00 | - |
| 2025-09-16 | Mr. Mark L. JacobsonCOO | -40,00k | 4,37M | Derivative Exercise and Sale | 4,85 - 114,23 | 0,00 | - |
| 2025-09-16 | Mr. Mark L. JacobsonCOO | -5,78k | 671,93k | Automatic Disposition | 116,19 | 0,00 | -100,00% |
| 2025-09-12 | Dr. Herriot TabuteauFounder, Chairman, CEO & President | -62,88k | 6,86M | Derivative Exercise and Sale | 8,02 - 118,96 | 7,23k | - |
| 2025-09-08 | Dr. Mark ColemanIndependent Lead Director | 1,58k | 200,47k | Kauf | 127,20 - 127,40 | 452,07k | 0,35% |
| 2025-09-05 | Mr. Mark E. SaadIndependent Director | -9,13k | 1,06M | Derivative Exercise and Sale | 9,00 - 125,07 | 10,30k | - |
| 2025-09-02 | Dr. Roger A. JeffsIndependent Director | -13,46k | 1,67M | Automatic Disposition | 123,68 | 57,51k | -18,97% |
| 2025-08-27 | Dr. Roger A. JeffsIndependent Director | -60,00k | 7,30M | Automatic Disposition | 121,27 - 122,30 | 70,97k | -45,81% |
| 2025-08-22 | Dr. Roger A. JeffsIndependent Director | -36,69k | 4,41M | Automatic Disposition | 120,03 - 120,08 | 130,97k | -21,88% |
| 2025-06-20 | Mr. Hunter MurdockGeneral Counsel & Secretary | -13,51k | 966,44k | Derivative Exercise and Sale | 29,91 - 102,47 | 0,00 | - |
| 2025-06-16 | Mr. Hunter MurdockGeneral Counsel & Secretary | -22,50k | 1,60M | Derivative Exercise and Sale | 29,91 - 102,42 | 0,00 | - |
| 2025-06-09 | Mr. Mark L. JacobsonCOO | -25,00k | 2,56M | Derivative Exercise and Sale | 8,02 - 110,44 | 5,78k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
